HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,129 | +172.8% | 81,934 | +157.6% | 0.03% | +181.8% |
| Q2 2023 | $1,147 | -59.2% | 31,807 | -56.8% | 0.01% | -67.6% |
| Q1 2023 | $2,811 | -21.0% | 73,629 | +17.7% | 0.03% | -32.0% |
| Q4 2022 | $3,559 | -99.5% | 62,562 | +252.6% | 0.05% | +525.0% |
| Q3 2022 | $701,000 | -79.7% | 17,745 | -77.4% | 0.01% | -78.9% |
| Q2 2022 | $3,448,000 | +141.3% | 78,374 | +120.5% | 0.04% | +375.0% |
| Q4 2021 | $1,429,000 | +62.6% | 35,547 | +68.5% | 0.01% | -11.1% |
| Q1 2021 | $879,000 | +260.2% | 21,092 | +53.0% | 0.01% | -10.0% |
| Q4 2019 | $244,000 | -23.5% | 13,789 | -33.1% | 0.01% | -33.3% |
| Q3 2019 | $319,000 | – | 20,606 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |